Literature DB >> 10535489

Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis?

M Nakajima1, H Shimizu, A Miyazaki, S Watanabe, N Kitami, N Sato.   

Abstract

Autoimmune cholangitis (AIC) has been proposed as a distinct disease entity from primary biliary cirrhosis (PBC), without antimitochondrial antibody (AMA) and anti-M2 antibody but with a high titer of antinuclear antibody (ANA) in the serum. However, negativity for AMA and anti-M2 antibody was determined by different methods in different studies. We hypothesized that anti-M2 antibody negativity in AIC resulted from methodological differences, including selection of the immunoglobulin subclass of the autoantibody. Twenty-three patients compatible with AIC whose serum tested negative for AMA and positive for ANA (> or = 1:80) were compared with 71 AMA-positive PBC patients. Laboratory findings, histology, and the pattern of anti-M2 antibody assessed by immunoblotting were compared. Alkaline phosphatase, total bilirubin, total cholesterol, and IgM values were lower in patients with AIC (P < 0.05, 0.01, respectively). Anti-smooth muscle antibody was detected more frequently in patients with AIC (P < 0.01). However, anti-M2 antibody was detected using immunoblotting not only in PBC but also in AIC cases. IgA class alone, IgM class alone, or both IgA and IgM classes of anti-M2 antibody were detected in 13%, 17%, and 22% of AIC patients, respectively, whereas they were not detected in PBC patients (P < 0.05, P < 0.01, P < 0.01). IgG class anti-M2 was detected in all patients with PBC, whereas it was detected in 48% of patients with AIC (P < 0.01). Histological evaluation showed that the early stages of disease were found more frequently in AIC (78%) than in PBC patients (39%) (P < 0.01). Anti-M2 antibody was detected by immunoblotting in all AIC patients. Hence, AIC is not a distinct disease from PBC. For diagnosing AIC and/or PBC, anti-M2 antibody should be examined by the immunoblotting assay to detect not only IgG but also IgA and IgM subclasses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10535489     DOI: 10.1007/s005350050380

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  8 in total

1.  Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxo-acid dehydrogenase complex in primary biliary cirrhosis.

Authors:  Jun-Ichi Masuda; Katsuhisa Omagari; Kazuo Ohba; Hiroaki Hazama; Yoshiko Kadokawa; Hideki Kinoshita; Kenji Hayashida; Kazuhiro Hayashida; Hiromi Ishibashi; Yasuni Nakanuma; Shigeru Kohno
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

2.  Is the new diagnostic scoring system of Zeniya and colleagues useful for autoimmune liver diseases?

Authors:  Norio Horiike; Morikazu Onji
Journal:  J Gastroenterol       Date:  2005-12       Impact factor: 7.527

Review 3.  Comprehensive review of autoantibodies in patients with hyper-IgM syndrome.

Authors:  Mohamed-Ridha Barbouche; Qubo Chen; Marco Carbone; Imen Ben-Mustapha; Zakera Shums; Mehdi Trifa; Federica Malinverno; Francesca Bernuzzi; Haiyan Zhang; Nourhen Agrebi; Gary L Norman; Christopher Chang; M Eric Gershwin; Pietro Invernizzi
Journal:  Cell Mol Immunol       Date:  2018-02-05       Impact factor: 11.530

Review 4.  Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases.

Authors:  Birgit Terjung; Ulrich Spengler
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

5.  Characterization of M2 antibodies in asymptomatic Chinese population.

Authors:  Xiao-Hua Jiang; Ren-Qian Zhong; Xiao-Yun Fan; Yin Hu; Feng An; Jian-Wen Sun; Xian-Tao Kong
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

6.  Construction and expression of a humanized M2 autoantigen trimer and its application in the diagnosis of primary biliary cirrhosis.

Authors:  Xiao-Hua Jiang; Ren-Qian Zhong; Sheng-Qian Yu; Yin Hu; Weng-Weng Li; Xian-Tao Kong
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

7.  Clinical significance of IgG antimitochondrial M2 antibody levels in primary biliary cholangitis: A single center study from China.

Authors:  Lina Feng; Kaihui Dong; Xiaoxue Zhang; Bo Ma; Lin Chen; Qianqian Yang; Qingling Chen; Xiaoyu Wen; Qinglong Jin
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

8.  Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.

Authors:  Stella Gabeta; Gary L Norman; Christos Liaskos; Panagiotis A Papamichalis; Theodoros Zografos; Athanasios Garagounis; Eirini I Rigopoulou; George N Dalekos
Journal:  J Clin Immunol       Date:  2007-05-21       Impact factor: 8.542

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.